GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (NAS:SXTC) » Definitions » Cash per Share

SXTC (China SXT Pharmaceuticals) Cash per Share : $5.44 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is China SXT Pharmaceuticals Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). China SXT Pharmaceuticals's Cash per Share for the quarter that ended in Mar. 2024 was $5.44.


China SXT Pharmaceuticals Cash per Share Historical Data

The historical data trend for China SXT Pharmaceuticals's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China SXT Pharmaceuticals Cash per Share Chart

China SXT Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash per Share
Get a 7-Day Free Trial 420.49 429.40 191.07 37.97 5.44

China SXT Pharmaceuticals Semi-Annual Data
Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 191.07 20.63 37.97 15.75 5.44

China SXT Pharmaceuticals Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

China SXT Pharmaceuticals's Cash per Share for the fiscal year that ended in Mar. 2024 is calculated as:

China SXT Pharmaceuticals's Cash per Share for the quarter that ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China SXT Pharmaceuticals  (NAS:SXTC) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


China SXT Pharmaceuticals Cash per Share Related Terms

Thank you for viewing the detailed overview of China SXT Pharmaceuticals's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


China SXT Pharmaceuticals Business Description

Traded in Other Exchanges
Address
No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, Advanced TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates a majority of its revenue from the People's Republic of China.

China SXT Pharmaceuticals Headlines

From GuruFocus

China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split

By GuruFocusNews GuruFocusNews 07-07-2022

China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split

By GuruFocusNews GuruFocusNews 06-07-2022